TTY Biopharm Company Limited (4105)
TWSE
Closed
Aug 25, 2026
Day's Range
77.8052 wk Range
71.60Overview - 4105 - TTY Biopharm Company Limited
Key Statistics
Valuation
Enterprise Value
19.50B
P/E (Trailing)
‪11.19‬
P/E (Forward)
‪12.87‬
PEG Ratio
‪12.87‬
Price / Sales (TTM)
‪2.91‬
Price / Book
‪2.79‬
EV / EBITDA
‪9.46‬
Profitability
Gross Margin
‪59.99%‬
Profit Margin
‪26.04%‬
Operating Margin
‪29.48%‬
Return on Assets
‪10.34%‬
Return on Equity
‪25.11%‬
Ownership
Shares Outstanding
248.64M
Float
192.42M
Held by Insiders
‪23.10%‬
Held by Institutions
‪13.18%‬
Price stats
Beta
‪0.11‬
50-Day Avg
‪76.43‬
200-Day Avg
‪78.74‬
Dividends
Payout Ratio
‪64.66%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - 4105 - TTY Biopharm Company Limited
Peers - 4105 - TTY Biopharm Company Limited
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.
Profile Summary - 4105 - TTY Biopharm Company Limited
About
TTY Biopharm Company Limited is a publicly traded pharmaceutical company specializing in the research, development, manufacture, and sale of pharmaceutical preparations. Established in 1960 and headquartered in Taipei, Taiwan, the company serves Taiwan’s pharmaceuticals and biotechnology sector, focusing primarily on…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
